N-Terminal Natriuretic Peptide and Ventilation-Perfusion Lung Scan in Sickle Cell Disease and Thalassemia Patients with Pulmonary Hypertension

• Published in: Hemoglobin Vol. 34; no. 1; pp. 78 - 94
• Main Authors: Mokhtar, Galila M., Adly, Amira A.M., Alfy, Mohsen S. El, Tawfik, Lamis M., Khairy, Ahmed T.
• Format: Journal Article
• Language: English
• Published: England Informa UK Ltd 01-01-2010; Taylor & Francis
• Subjects: Adolescent; Adult; Anemia, Sickle Cell - blood; Anemia, Sickle Cell - complications; Anemia, Sickle Cell - diagnosis; beta-Thalassemia - blood; beta-Thalassemia - complications; beta-Thalassemia - diagnosis; Child; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary - blood; Hypertension, Pulmonary - diagnosis; Hypertension, Pulmonary - etiology; Male; N-terminal pro-brain natriuretic peptide (NT-pro-BNP); Natriuretic Peptide, Brain - blood; Peptide Fragments - blood; Prospective Studies; Pulmonary hypertension (PH); Regression Analysis; Sickle cell disease; Thalassemia; Ventilation-Perfusion Ratio; Young Adult
• ISSN: 0363-0269; 1532-432X
• DOI: 10.3109/03630260903554621

The aim of this study was to determine the prevalence of pulmonary hypertension (PH) in sickle cell disease and thalassemia patients in relation to clinical and laboratory parameters of hemolysis and hemosidersosis, as well as plasma N-terminal pro-brain natriuretic peptide (NT-pro-BNP). The study also aimed to define the role of thromboembolic pulmonary artery (PA) obstruction in its etiology. Forty sickle cell disease and 30 thalassemia patients [15 β-thalassemia major (β-TM) and 15 β-thalassemia intermedia (β-TI)] were screened for PH defined as tricuspid regurgitant velocity (TRV) >2.5 m sec and evaluated for PA obstruction using ventilation-perfusion lung scan (V Q), together with measurement of their plasma levels of NT-pro-BNP. Patients were prospectively followed up for a mean of 18 ± 6.1 months. The prevalence of PH was 37.5, 40.0 and 26.7% in sickle cell disease, β-TI and β-TM patients, respectively. Pulmonary hypertension patients were older, had longer disease duration, higher serum ferritin, serum lactate dehydrogenase (LDH) and NT-pro-BNP with lower hemoglobin (Hb) levels compared to patients without PH. N-terminal pro-BNP was positively correlated with duration of illness, TRV, LDH, serum ferritin, and negatively correlated with Hb levels. The strongest predictor for TRV was serum ferritin followed by the NT-pro-BNP level. Forty-six-point-seven percent of sickle cell disease patients with PH had either high or intermediate probability V Q scan results compared to 10% of thalassemic patients with PH who had high probability V Q scan results. Pulmonary hypertension is highly prevalent in young sickle cell disease and thalassemia patients, where elevated serum ferritin and NT-pro-BNP are the main indicators.